CN104963029B - 可降解复合纳米纤维及其制备方法和用途 - Google Patents
可降解复合纳米纤维及其制备方法和用途 Download PDFInfo
- Publication number
- CN104963029B CN104963029B CN201510444678.3A CN201510444678A CN104963029B CN 104963029 B CN104963029 B CN 104963029B CN 201510444678 A CN201510444678 A CN 201510444678A CN 104963029 B CN104963029 B CN 104963029B
- Authority
- CN
- China
- Prior art keywords
- polylactic acid
- star
- composite nano
- preparation
- nano fiber
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002121 nanofiber Substances 0.000 title claims abstract description 61
- 239000002131 composite material Substances 0.000 title claims abstract description 54
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 229920000747 poly(lactic acid) Polymers 0.000 claims abstract description 53
- 239000004626 polylactic acid Substances 0.000 claims abstract description 53
- 239000000463 material Substances 0.000 claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 17
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 claims abstract description 13
- 238000010041 electrostatic spinning Methods 0.000 claims abstract description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 27
- 229920001610 polycaprolactone Polymers 0.000 claims description 25
- 239000000178 monomer Substances 0.000 claims description 14
- 229940059574 pentaerithrityl Drugs 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 11
- 239000003999 initiator Substances 0.000 claims description 10
- 239000003054 catalyst Substances 0.000 claims description 9
- 239000012456 homogeneous solution Substances 0.000 claims description 9
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 claims description 9
- KSBAEPSJVUENNK-UHFFFAOYSA-L tin(ii) 2-ethylhexanoate Chemical compound [Sn+2].CCCCC(CC)C([O-])=O.CCCCC(CC)C([O-])=O KSBAEPSJVUENNK-UHFFFAOYSA-L 0.000 claims description 8
- 238000000465 moulding Methods 0.000 claims description 7
- 239000011259 mixed solution Substances 0.000 claims description 6
- 210000002950 fibroblast Anatomy 0.000 claims description 3
- 230000008901 benefit Effects 0.000 abstract description 3
- -1 polytrimethylene carbonate Polymers 0.000 abstract description 3
- 230000010261 cell growth Effects 0.000 abstract description 2
- 230000024245 cell differentiation Effects 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 239000004632 polycaprolactone Substances 0.000 abstract 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 abstract 1
- 238000009827 uniform distribution Methods 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 24
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 20
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 9
- 238000001291 vacuum drying Methods 0.000 description 9
- 238000005227 gel permeation chromatography Methods 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 125000005474 octanoate group Chemical group 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 238000010612 desalination reaction Methods 0.000 description 5
- 239000012046 mixed solvent Substances 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 230000010355 oscillation Effects 0.000 description 5
- 210000000845 cartilage Anatomy 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000001746 injection moulding Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 229910021642 ultra pure water Inorganic materials 0.000 description 4
- 239000012498 ultrapure water Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 241001484259 Lacuna Species 0.000 description 3
- 241000209094 Oryza Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 210000001612 chondrocyte Anatomy 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229920002988 biodegradable polymer Polymers 0.000 description 2
- 239000004621 biodegradable polymer Substances 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000002657 fibrous material Substances 0.000 description 2
- JBFHTYHTHYHCDJ-UHFFFAOYSA-N gamma-caprolactone Chemical compound CCC1CCC(=O)O1 JBFHTYHTHYHCDJ-UHFFFAOYSA-N 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- DJOWTWWHMWQATC-KYHIUUMWSA-N Karpoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1(O)C(C)(C)CC(O)CC1(C)O)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C DJOWTWWHMWQATC-KYHIUUMWSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229920006237 degradable polymer Polymers 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 125000003963 dichloro group Chemical group Cl* 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002055 immunohistochemical effect Effects 0.000 description 1
- 238000011532 immunohistochemical staining Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000002648 laminated material Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000002070 nanowire Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920001432 poly(L-lactide) Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 229950003937 tolonium Drugs 0.000 description 1
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Artificial Filaments (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510444678.3A CN104963029B (zh) | 2015-07-27 | 2015-07-27 | 可降解复合纳米纤维及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510444678.3A CN104963029B (zh) | 2015-07-27 | 2015-07-27 | 可降解复合纳米纤维及其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104963029A CN104963029A (zh) | 2015-10-07 |
CN104963029B true CN104963029B (zh) | 2017-01-04 |
Family
ID=54217107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510444678.3A Active CN104963029B (zh) | 2015-07-27 | 2015-07-27 | 可降解复合纳米纤维及其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104963029B (zh) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1876926A (zh) * | 2006-07-04 | 2006-12-13 | 薛占强 | 一种可生物降解防止术后粘连的纳米纤维无纺织物及制备 |
CN101525789B (zh) * | 2009-03-10 | 2011-04-27 | 东华大学 | 聚ε-己内酯和聚三亚甲基碳酸酯复合纳米纤维及其制备和应用 |
CN101949071B (zh) * | 2010-09-16 | 2012-04-18 | 扬州大学 | 一种生物可降解复合纤维的生产方法 |
US9180228B2 (en) * | 2011-10-03 | 2015-11-10 | Abbott Cardiovascular Systems Inc. | Rubber toughened bioresorbable polymer peripheral scaffolds |
KR101374467B1 (ko) * | 2012-02-02 | 2014-03-19 | 서울대학교산학협력단 | X-선 조영이 가능한 의료용 물품 및 이의 제조방법 |
CN102675844A (zh) * | 2012-06-05 | 2012-09-19 | 云南民族大学 | 聚乳酸组合物及其制备方法 |
KR101410887B1 (ko) * | 2012-08-08 | 2014-07-02 | 강원대학교산학협력단 | 카테콜화 나노섬유, 그 제조방법 및 그 용도 |
CN103432630B (zh) * | 2013-09-06 | 2015-03-18 | 烟台隽秀生物科技有限公司 | 一种双网交织复合神经导管的制备方法 |
-
2015
- 2015-07-27 CN CN201510444678.3A patent/CN104963029B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN104963029A (zh) | 2015-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gupta et al. | Poly (lactic acid) fiber: An overview | |
CN101623517B (zh) | 一种医用防粘连膜及其制备方法 | |
An et al. | Preparation of fish gelatin and fish gelatin/poly (l-lactide) nanofibers by electrospinning | |
He et al. | Tissue engineering scaffolds electrospun from cotton cellulose | |
Huang et al. | Functional polyhedral oligomeric silsesquioxane reinforced poly (lactic acid) nanocomposites for biomedical applications | |
CN101780292B (zh) | 以纤维蛋白原为基础的三维多孔纳米支架及其制备方法 | |
CN105525441A (zh) | 一种可折叠多层交联复合纤维网膜及其制备方法与应用 | |
CN107648669A (zh) | 构建血管化组织工程骨膜的方法 | |
CN105504248B (zh) | 可调控弹性和形状记忆效应的线性可降解聚酯弹性体的制备及应用 | |
CN101417150B (zh) | 脂肪族聚酯-壳聚糖复合纤维组织修复支架的制备方法 | |
CN106310370A (zh) | 一种弹性可降解生物医用材料的制备方法 | |
Thomas et al. | Electrospinning of Biosyn®-based tubular conduits: structural, morphological, and mechanical characterizations | |
CN101288777A (zh) | 聚己内酯/聚乙二醇组织工程支架材料及其制备 | |
CN102908667B (zh) | 部分可吸收的纤维膜疝气补片的制备方法 | |
CN106390196A (zh) | 一种纳米纤维神经组织工程支架的制备方法 | |
CN101653624A (zh) | 复合纳米纤维小直径血管组织工程支架材料的制备方法 | |
CN103751839A (zh) | 一种聚乳酸和壳聚糖复合神经导管及其制备方法 | |
CN109097910A (zh) | Pgs/聚乳酸核壳结构纳米纤维膜的制备与应用 | |
CN102277659A (zh) | 一种水稳定性γ-聚谷氨酸纳米纤维的制备方法 | |
CN110592947A (zh) | 聚羟基脂肪酸酯/聚多巴胺复合电纺丝膜的制备方法及电纺丝膜 | |
KR100953366B1 (ko) | 조직재생용 나노섬유 지지체 및 이의 제조방법 | |
CN104287869B (zh) | 一种用于气管移植的新型纳米纤维膜/纱支架及其制备方法 | |
Zhu et al. | Evaluation of electrospun PCL diol-based elastomer fibers as a beneficial matrix for vascular tissue engineering | |
CN102908668A (zh) | 诱导生长型可吸收补片的制备方法 | |
CN109943974B (zh) | 基于聚羟基脂肪酸酯/明胶电纺纳米纤维的神经导管材料的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191128 Address after: 537100 Second Floor, No. 4 Fuji New Town, Jingang Avenue, Gangbei District, Guigang City, Guangxi Zhuang Autonomous Region Patentee after: Guigang Ruicheng Technology Co., Ltd. Address before: 251500 Linyi County People's Hospital of Shandong province intravenous drug allocation section Patentee before: Cao Jing |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200601 Address after: No.110, group 35, Qujing village, Guizhuang, Shaxi Town, Taicang City, Suzhou City, Jiangsu Province Patentee after: Suzhou jinlaite Chemical Fiber Co., Ltd Address before: 537100 Second Floor, No. 4 Fuji New Town, Jingang Avenue, Gangbei District, Guigang City, Guangxi Zhuang Autonomous Region Patentee before: GUIGANG RUICHENG TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |